Niklas Mattsson-Carlgren, Henrik Zetterberg, Kaj Blennow, Ulf Andréasson on Blood Neurofilament Light a Promising Biomarker for Alzheimer’s?
COMMENT We agree with Dr. Aisen that plasma NfL may potentially be useful as a biomarker for prescreening individuals who are selected for further testing before inclusion in early intervention trials. We think this is one of the most interesting possible future